MedPath

A New More Efficient Cycloplegia Scheme

Phase 4
Conditions
Refractive Errors
Interventions
Drug: Cyclopentolate+tropicamide+phenylephrine
Registration Number
NCT02177539
Lead Sponsor
Pontificia Universidad Catolica de Chile
Brief Summary

The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme)

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Children between 1 and 10 years
Exclusion Criteria
  • Strabismus
  • Ocular surgery
  • Another ocular disease than ametropias (i.e uveitis, cataract)
  • Cardiovascular or neurologic disease.
  • Allergy to any of drugs used in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CyclopentolateCyclopentolate+tropicamide+phenylephrine-
CyclopentolateCyclopentolate-
Cyclopentolate+tropicamide+phenylephrineCyclopentolate-
Cyclopentolate+tropicamide+phenylephrineCyclopentolate+tropicamide+phenylephrine-
Primary Outcome Measures
NameTimeMethod
Change in Spherical equivalentaverage 18 days

In the first and second visit the spherical equivalent will be measured with retinoscopy.

Change in spherical equivalent refraction from first visit to day average 18 days (second visit). On both visits the patient will receive different cyclopegia schemes.

Secondary Outcome Measures
NameTimeMethod
Change in spherical refractionaverage 18 days

Change in spherical refraction between visit 1 and 2.

Change in cylindrical refractionaverage 18 days

Change in cylindrical refraction between visit 1 and 2

iris motilityaverage 18 days

both schemes are effective in cycloplegia ? In visit 1 and 2 the iris motility after the cyclopegic schemes will be evaluated

Trial Locations

Locations (1)

Pontificia Universidad Catolica de Chile, Departamento de Oftalmología

🇨🇱

Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath